Much has been said about UK spinouts being at risk of being swallowed up by conglomerates (“UK biotech keeps selling itself to America”, Report, January 28) but it’s no surprise that growing companies ...

The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO ...

UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.

Biotech may be crawling out of its long funding winter, but early-stage firms are still shivering. After years of weak valuations, stubbornly high borrowing costs and regulatory uncertainty, UK ...

Major reforms to the United Kingdom’s national research funding agency are aimed at boosting the nation’s economy.

Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ACCESS Newswire / February 12, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" ...

Billions of pounds worth of export and investment deals for the UK have been secured, as the Prime Minister wraps up his ...

Velocity Clinical Research today announces the appointment of Dr. Ronnie Beboso as UK Medical Director, strengthening the organization's medical leadership as it continues to scale its clinical ...

THE FTSE 100 hit another record yesterday — shrugging off a rough day for global markets as investors piled into the UK index ...

An official release said the 71 new projects for which Mr Stalin laid the foundation <br />stone at the Conclave, involved a committed investment of Rs 36,968 crore and <br />offer jobs to 60,823 ...

The Duke of Edinburgh helped to open a £400m expansion at Fujifilm's biotechnology factory in Billingham.

The expanded 1.6million sqft site is designed to be part of the Japanese firm's global network of medicine factories ...